CXCL12 and psoriasis vulgaris: Abdelaal et al. described CXCL12/SDF-1 expression in skin biopsies of patients with psoriasis vulgaris and psoriatic arthritis (PsA) during 6-week methotrexate (MTX) therapy compared to healthy volunteers.